Abstract
There are no radioprotectors currently approved by the United States Food and Drug Administration (US FDA) for either the hematopoietic acute radiation syndrome (H-ARS) or for the acute radiation g...
Funding Information
  • Department of Defense (DM178016)

This publication has 95 references indexed in Scilit: